1519P Fruquintinib plus sintilimab in patients (pts) with either treatment-naïve or previously treated advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: Results from a multicenter, single-arm phase II study

Abstract

An abstract is not available for this record. Please visit the publisher website for more details.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now